Stabilized liquid agrochemical compositions are provided that comprise flowable, aqueous dispersion concentrates comprising a) a continuous aqueous liquid phase; b) at least one dispersed, solid phase comprising a dispersion of polymer particles having a mean particle size of at least one micron, wherein the outside surfaces of the particles comprise a colloidal solid material and wherein the particles have at least one agrochemically active ingredient distributed therein, optionally a non-porous particulate mineral that acts as a diffusion barrier to slow the release of the active ingredient, and optionally at least one non-cross-linkable mobile chemical such that the extraction of this chemical from the disperse phase renders it porous in a manner that allows the active ingredient to diffuse out. The colloidal solid is used to stabilize the polymerizable resin in an emulsion state during preparation. In one embodiment, the agrochemically active ingredient is a solid and is distributed within the dispersed solid phase or is a liquid and is distributed within the dispersed solid phase. The compositions of the invention can be used directly or with dilution to combat pests or as plant growth regulators.

The present application an IDL6 mature polypeptide plant aging promoter, and a preparation method and application thereof, belonging to the field of plant aging promoters. The IDL6 mature polypeptide plant aging promoter is with an IDL6 mature polypeptide as a main functional component, and the IDL6 mature polypeptide having the following amino acid sequence: F-G-S-L-V-L-N-A-L-P-K-G-S-V-P-A-S-G-P-S-K-R-I-N. The provided plant aging promoter can promote the leaf senescence of the plant, accelerate the senescence, and has no other additional bad performance, and has extremely strong field operability.

The present application an IDL6 mature polypeptide plant aging promoter, and a preparation method and application thereof, belonging to the field of plant aging promoters. The IDL6 mature polypeptide plant aging promoter is with an IDL6 mature polypeptide as a main functional component, and the IDL6 mature polypeptide having the following amino acid sequence: F-G-S-L-V-L-N-A-L-P-K-G-S-V-P-A-S-G-P-S-K-R-I-N. The provided plant aging promoter can promote the leaf senescence of the plant, accelerate the senescence, and has no other additional bad performance, and has extremely strong field operability.

The present application an IDL6 mature polypeptide plant aging promoter, and a preparation method and application thereof, belonging to the field of plant aging promoters. The IDL6 mature polypeptide plant aging promoter is with an IDL6 mature polypeptide as a main functional component, and the IDL6 mature polypeptide having the following amino acid sequence: F-G-S-L-V-L-N-A-L-P-K-G-S-V-P-A-S-G-P-S-K-R-I-N. The provided plant aging promoter can promote the leaf senescence of the plant, accelerate the senescence, and has no other additional bad performance, and has extremely strong field operability.

The invention relates to the use of benzyl alcohol as a systemic herbicide. The invention also relates to a method for controlling weeds or undesired plants, which includes applying a composition comprising the benzyl alcohol herbicide to harmful or undesired plants, or to parts of these harmful or undesired plants, or else to the fields where these weeds or undesired plants are growing.

The invention relates to the use of benzyl alcohol as a systemic herbicide. The invention also relates to a method for controlling weeds or undesired plants, which includes applying a composition comprising the benzyl alcohol herbicide to harmful or undesired plants, or to parts of these harmful or undesired plants, or else to the fields where these weeds or undesired plants are growing.

Provided herein are synthetic peptides with enhanced antimicrobial and antibiofilm characteristics, and are biocompatible with mammalian cellular systems. The disclosed synthetic antimicrobial moieties include a mastoparan peptide having SEQ ID NO:1 and a pentapeptide motif formed from phenylalanine, leucine, proline, and two isoleucine residues, wherein the pentapeptide motif is conjugated the N-terminus of the mastoparan peptide. Also provided are compositions comprising the synthetic peptides, as well as methods of treating a microbial infection or removing a biofilm using the peptides.

Identification and elimination of micro-organisms in the air, on surfaces and on objects that are stationary or in motion using artificial intelligence and machine learning algorithms.

Identification and elimination of micro-organisms in the air, on surfaces and on objects that are stationary or in motion using artificial intelligence and machine learning algorithms.

A method of treating a patient who has hepatocellular carcinoma (HCC), colorectal carcinoma (CRC), glioblastoma (GB), gastric cancer (GC), esophageal cancer, NSCLC, pancreatic cancer (PC), renal cell carcinoma (RCC), benign prostate hyperplasia (BPH), prostate cancer (PCA), ovarian cancer (OC), melanoma, breast cancer (BRCA), CLL, Merkel cell carcinoma (MCC), SCLC, Non-Hodgkin lymphoma (NHL), AML, gallbladder cancer and cholangiocarcinoma (GBC, CCC), urinary bladder cancer (UBC), and uterine cancer (UEC) includes administering to said patient a composition containing a population of activated T cells that selectively recognize cells in the patient that aberrantly express a peptide. A pharmaceutical composition contains activated T cells that selectively recognize cells in a patient that aberrantly express a peptide, and a pharmaceutically acceptable carrier, in which the T cells bind to the peptide in a complex with an MHC class I molecule, and the composition is for treating the patient who has HCC, CRC, GB, GC, esophageal cancer, NSCLC, PC, RCC, BPH, PCA, OC, melanoma, BRCA, CLL, MCC, SCLC, NHL, AML, GBC, CCC, UBC, and/or UEC. A method of treating a patient who has HCC, CRC, GB, GC, esophageal cancer, NSCLC, PC, RCC, BPH, PCA, OC, melanoma, BRCA, CLL, MCC, SCLC, NHL, AML, GBC, CCC, UBC, and/or UEC includes administering to said patient a composition comprising a peptide in the form of a pharmaceutically acceptable salt, thereby inducing a T-cell response to the HCC, CRC, GB, GC, esophageal cancer, NSCLC, PC, RCC, BPH, PCA, OC, melanoma, BRCA, CLL, MCC, SCLC, NHL, AML, GBC, CCC, UBC, and/or UEC.